Founded December 2018
Stage Technology development
Investor Trendlines Medical Singapore
Contact Project Manager Troy Bailey
Continale Medical is developing a device to alleviate stress urinary incontinence (SUI). The product idea was conceived by Trendlines Labs.
Prototypes were developed in partnership with clinicians from Singapore General Hospital and with funding from the Singapore-Israel Industrial Research & Development (SIIRD) Foundation.
PCT examination completed, currently undergoing National phase examination in four jurisdictions.
Troy Bailey is passionate about health care and delivering value. He brings his 20 years of deep expertise in building and leading businesses and sales channels, as well as to acquisitions, integrations, and organizational transformations; broad experience in medical devices, advanced wound care, biologics, nutraceuticals, and OTC products across the Asia Pacific region, Middle East, Africa, Turkey, and Israel.
Previously, a Senior Director of Ontogenix Pte. Ltd. and leadership positions in private equity-owned and public companies (Everlife Pte. Ltd, Acelity, GE Healthcare, and Johnson & Johnson).
SUI occurs when urine leaks out due to sudden pressure (or stress) exerted on the bladder and urethra, for example, during physical activity, coughing, laughing or sneezing. SUI is more common in women than men, affecting more than 200 million women worldwide.*
*Sources: Irwin et al. BJU Int. 2011 Oct;108(7):1132-8 and Global Forum on Incontinence, 2018 (PDF) prevalence of urinary incontinence (UI) globally >400 million people; SUI is 51% of UI; therefore total female SUI >200 million.
